We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Latham Group
SWIM
$908M
| $225K | ﹤0.01% |
78,707
-1,840
| -2% | -$6.46K |
|
1102
Corteva
CTVA
$50.3B
| $222K | ﹤0.01% |
3,683
-190,449
| -98% | -$11.6M |
|
1103
Ryman Hospitality Properties
RHP
$7.91B
| $221K | ﹤0.01% |
+2,465
| New | +$219K |
|
1104
CNB Financial Corp
CCNE
$1.04B
| $221K | ﹤0.01% |
11,518
-250
| -2% | -$5.72K |
|
1105
Realty Income
O
$59.8B
| $221K | ﹤0.01% |
3,488
+165
| +5% | +$10.7K |
|
1106
Bank of Marin Bancorp
BMRC
$465M
| $220K | ﹤0.01% |
10,029
-8,000
| -44% | -$231K |
|
1107
Arrowhead Research
ARWR
$12.3B
| $216K | ﹤0.01% |
8,510
-4,499
| -35% | -$142K |
|
1108
ONE Gas
OGS
$5.09B
| $215K | ﹤0.01% |
+2,717
| New | +$215K |
|
1109
Corcept Therapeutics
CORT
$12B
| $214K | ﹤0.01% |
9,895
-48,101
| -83% | -$1.05M |
|
1110
Yeti Holdings
YETI
$3.37B
| $214K | ﹤0.01% |
+5,354
| New | +$221K |
|
1111
Praxis Precision Medicines
PRAX
$10.6B
| $213K | ﹤0.01% |
17,592
+8,770
| +99% | +$370K |
|
1112
TETRA Technologies
TTI
$1.29B
| $213K | ﹤0.01% |
80,490
+10,354
| +15% | +$36K |
|
1113
Ameresco
AMRC
$1.46B
| $213K | ﹤0.01% |
4,332
-525
| -11% | -$27.8K |
|
1114
Welltower
WELL
$169B
| $212K | ﹤0.01% |
+2,960
| New | +$215K |
|
1115
Sutro Biopharma
STRO
$359M
| $212K | ﹤0.01% |
4,585
-1,727
| -27% | -$110K |
|
1116
Myers Industries
MYE
$1.27B
| $210K | ﹤0.01% |
9,805
-2,162
| -18% | -$49.2K |
|
1117
Schrodinger
SDGR
$1.38B
| $207K | ﹤0.01% |
+7,873
| New | +$187K |
|
1118
GrafTech
EAF
$207M
| $205K | ﹤0.01% |
4,209
+570
| +16% | +$30.8K |
|
|
EFOR
1119
Everforth Inc
EFOR
$1.32B
| $202K | ﹤0.01% |
2,446
-4,010
| -62% | -$348K |
|
1120
Macy's
M
$6.19B
| $201K | ﹤0.01% |
11,483
-21,406
| -65% | -$453K |
|
1121
Popular Inc
BPOP
$11.3B
| $201K | ﹤0.01% |
3,498
-30,585
| -90% | -$1.99M |
|
1122
Dow Inc
DOW
$22.1B
| $200K | ﹤0.01% |
+3,657
| New | +$206K |
|
1123
DraftKings
DKNG
$12.5B
| $199K | ﹤0.01% |
10,276
-2,158
| -17% | -$35.9K |
|
1124
Comstock Resources
CRK
$4B
| $198K | ﹤0.01% |
18,388
-5,469
| -23% | -$65K |
|
|
PR
1125
Permian Resources
PR
$17.7B
| $198K | ﹤0.01% |
18,861
-91,591
| -83% | -$935K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.